Market Overview:
The global contraceptive drugs and devices market is expected to grow at a CAGR of 6.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing awareness about contraception, rising prevalence of sexually transmitted infections (STIs), and growing demand for long-acting reversible contraceptives (LARCs). Based on type, the global contraceptive drugs and devices market is segmented into oral contraceptives, vaginal contraceptives, injectable contraceptive drugs, and male/female contraceptive devices. Oral contraceptives are further sub-segmented into combined oral contraceptives (COCs) and progestin-only pills (POPs). Vaginal contraception includes products such as spermicides, vaginal rings, diaphragms with spermicide gel or cream applicators), female condoms. Injectable contraception drugs are further sub-segmented into depot medroxyprogesterone acetate (DMPA) injections and norethisterone enanthate injections. Male/female contraceptive devices include male condoms, female condoms,, intrauterine systems (IUSs), transdermal patches,, cervical caps,, vaginal barriers,. Based on application, the global contraceptive drugs and devices market is segmented into hospitals pharmacies,, clinics,, retail pharmacies,. Hospitals are expected to account for the largest share of this market in 2018 owing to their large patient base across all regions.
Product Definition:
A contraceptive drug or device is a medication or device that is used to prevent pregnancy. Contraceptive drugs and devices are important because they can help people avoid unplanned pregnancies.
Oral:
Oral Contraceptive Drugs and Devices Market Size, Share & Trends Analysis Report By Drug Type (Pill, Patch), By Route of Administration (Injectable, Oral), By End-use (Hospitals & Clinics, Home Healthcare) And Segment Forecasts To 2022 -> Global oral contraceptive drugs and devices market size was valued at over USD 1.0 billion in 2014.
Vaginal:
Vaginal Ring is a flexible, plastic device that is inserted into the vagina and then locked inside it. It has two main components: a hormone- releasing mechanism (a small battery-operated pump) and an applicator (a thin, plastic tube). The ring can last for up to three years.
Application Insights:
The others application segment includes clinics, private practices and individuals. These are the most common places where contraceptives are obtained and used by individuals as it is convenient. The other places where contraceptives can be obtained include hospitals, pharmacies and clinics. However these are the most popularly used locations for obtaining contraceptives henceforth Hospitals/Clinics/Pharmacies accounted for more than 50% of overall market share in 2017 due to easy availability of methods along with high awareness about them among women across developing countries such as India, China etc.
Moreover, a rise in population especially in developing countries will increase demand for family planning services which will further boost this market growth over the forecast period.
Regional Analysis:
Asia Pacific is expected to be the fastest-growing region during the forecast period. The growth of this region can be attributed to increasing awareness regarding contraceptive drugs and devices, rising demand for family planning services, and growing disposable income in developing countries such as China & India. In addition, supportive government initiatives are anticipated to fuel market growth over the forecast period. For instance, in September 2016, WHO and UNFPA launched a new initiative called “Unescoâ€s Every Woman Program†with an aim to increase access & availability of modern contraception methods among women worldwide by 2020.
Key regions analyzed in this study are North America; Europe; Asia Pacific (excluding China); and Latin America.
Growth Factors:
- Increasing awareness about contraception and its benefits: There is a growing awareness among people about contraception and its various benefits. This is driving the demand for contraceptive drugs and devices.
- Rise in incidence of unplanned pregnancies: The incidence of unplanned pregnancies is on the rise, which is fueling the demand for contraceptive drugs and devices.
- Growing population: The population is growing at a rapid pace, which is leading to an increase in the demand for contraceptives worldwide.
- Increased focus on family planning: There has been an increased focus on family planning in recent years, which has led to an increase in the use of contraceptives globally.
Scope Of The Report
Report Attributes
Report Details
Report Title
Contraceptive Drugs and Devices Market Research Report
By Type
Oral, Vaginal, Injectable Contraceptive Drugs, Male/Female Contraceptive Devices
By Application
Hospitals, Pharmacies, Others
By Companies
Bayer Healthcare, Merck, Church & Dwight, Warmer Chilcott, Agile Therapeutics, Pfizer, BioSante Pharmaceuticals, Mayer Laboratories, Pantarhei Bioscience, Teva Pharmaceutical Industries, Bayer Healthcare
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
215
Number of Tables & Figures
151
Customization Available
Yes, the report can be customized as per your need.
Global Contraceptive Drugs and Devices Market Report Segments:
The global Contraceptive Drugs and Devices market is segmented on the basis of:
Types
Oral, Vaginal, Injectable Contraceptive Drugs, Male/Female Contraceptive Devices
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Pharmacies, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Bayer Healthcare
- Merck
- Church & Dwight
- Warmer Chilcott
- Agile Therapeutics
- Pfizer
- BioSante Pharmaceuticals
- Mayer Laboratories
- Pantarhei Bioscience
- Teva Pharmaceutical Industries
- Bayer Healthcare
Highlights of The Contraceptive Drugs and Devices Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Oral
- Vaginal
- Injectable Contraceptive Drugs
- Male/Female Contraceptive Devices
- By Application:
- Hospitals
- Pharmacies
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Contraceptive Drugs and Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Contraceptive drugs and devices are medications or devices used to prevent pregnancy. They can be taken by women to prevent pregnancy, or they can be given to a woman who is already pregnant in order to help keep her baby from being born prematurely.
Some of the key players operating in the contraceptive drugs and devices market are Bayer Healthcare, Merck, Church & Dwight, Warmer Chilcott, Agile Therapeutics, Pfizer, BioSante Pharmaceuticals, Mayer Laboratories, Pantarhei Bioscience, Teva Pharmaceutical Industries, Bayer Healthcare.
The contraceptive drugs and devices market is expected to grow at a compound annual growth rate of 6.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Contraceptive Drugs and Devices Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Contraceptive Drugs and Devices Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Contraceptive Drugs and Devices Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Contraceptive Drugs and Devices Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Contraceptive Drugs and Devices Market Size & Forecast, 2020-2028
4.5.1 Contraceptive Drugs and Devices Market Size and Y-o-Y Growth
4.5.2 Contraceptive Drugs and Devices Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Oral
5.2.2 Vaginal
5.2.3 Injectable Contraceptive Drugs
5.2.4 Male/Female Contraceptive Devices
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Pharmacies
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Contraceptive Drugs and Devices Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Contraceptive Drugs and Devices Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Oral
9.6.2 Vaginal
9.6.3 Injectable Contraceptive Drugs
9.6.4 Male/Female Contraceptive Devices
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Pharmacies
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Oral
10.6.2 Vaginal
10.6.3 Injectable Contraceptive Drugs
10.6.4 Male/Female Contraceptive Devices
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Pharmacies
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Oral
11.6.2 Vaginal
11.6.3 Injectable Contraceptive Drugs
11.6.4 Male/Female Contraceptive Devices
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Pharmacies
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Oral
12.6.2 Vaginal
12.6.3 Injectable Contraceptive Drugs
12.6.4 Male/Female Contraceptive Devices
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Pharmacies
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Oral
13.6.2 Vaginal
13.6.3 Injectable Contraceptive Drugs
13.6.4 Male/Female Contraceptive Devices
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Pharmacies
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Contraceptive Drugs and Devices Market: Competitive Dashboard
14.2 Global Contraceptive Drugs and Devices Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Bayer Healthcare
14.3.2 Merck
14.3.3 Church & Dwight
14.3.4 Warmer Chilcott
14.3.5 Agile Therapeutics
14.3.6 Pfizer
14.3.7 BioSante Pharmaceuticals
14.3.8 Mayer Laboratories
14.3.9 Pantarhei Bioscience
14.3.10 Teva Pharmaceutical Industries
14.3.11 Bayer Healthcare
